[1] 裴福兴.加强基础与临床研究,努力提高我国股骨头坏死总体诊疗水平[J].中华骨科杂志,2010,30(1):3-5.
[2] Wei BF, Ge XH.Treatment of osteonecrosis of the femoral head with core decompression and bone grafting. Hip Int. 2011;21(2):206-210.
[3] Eward WC, Rineer CA, Urbaniak JR, et al. The vascularized fibular graft in precollapse osteonecrosis:is long-term hip preservation possible? Clin Orthop Relat Res. 2012;470: 2819-2826.
[4] Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head:Five year follow-up of a prospective controlled study. Bone. 2011;49:1005-1009.
[5] Liu Y, Liu S, Su X. Core decompression and implantation of bone marrow mononuclear cells with porous hydroxylapatite composite filler for the treatment of osteonecrosis of the femoral head. Arch Orthop Trauma Surg. 2013;133: 125-133.
[6] Zhao D, Cui D, Wang B, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50:325-330.
[7] Sen RK, Tripathy SK, Aggarwal S, et al. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study. J Arthroplasty. 2012;27:679-686.
[8] Ito H, Tanino H, Yamanaka Y, et al. Long-term results of conventional varus half-wedge proximal femoral osteotomy for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Br. 2012;94:308-314.
[9] Issa K, Naziri Q, Rasquinha VJ, et al. Outcomes of Primary Total Hip Arthroplasty in Systemic Lupus Erythematosus With a Proximally-Coated Cementless Stem. J Arthroplasty. 2013; 28(9):1663-1666..
[10] Issa K, Johnson AJ, Naziri Q, et al. Hip Osteonecrosis:Does Prior Hip Surgery Alter Outcomes Compared to an Initial Primary Total Hip Arthroplasty? J Arthroplasty. 2013;29(1): 162-166.
[11] Issa K, Naziri Q, Maheshwari AV, et al. Excellent Results and Minimal Complications of Total Hip Arthroplasty in Sickle Cell Hemoglobinopathy at Mid-Term Follow-Up Using Cementless Prosthetic Components. J Arthroplasty. 2013;28(9): 1693-1698.
[12] Mont MA,Hungerford DS.Non traumatic avascular necrosis of the femoral head.J Bone Joint Surg Am. 1995;77:459-474.
[13] Sugano N, Atsumi T, Ohzono K, et al. The 2001 revised criteria for diagnosis,classification,and st aging of idiopathic osteonecrosis of the femoral head. J Orthop Sci. 2002;7(5): 601-605.
[14] 王光忠,王少珠.头颈开窗带缝匠肌髂骨瓣移植治疗股骨头缺血性坏死33例报告[J].山东医药,1999,39(16):55.
[15] Wang BL, Sun W, Shi ZC, et al. Treatment of nontraumatic osteonecrosis of the femoral head using bone impaction grafting through a femoral neck window. Int Orthop. 2010; 34(5):635-639.
[16] 李鹏,金群华,陆志东,等.打压植骨治疗早中期股骨头无菌性坏死37例临床分析[J].宁夏医学杂志,2011,33(12):1195-1196.
[17] Zhao D, Wang B, Guo L, et al.Will a vascularized greater trochanter graft preserve the necrotic femoral head.Clin Orthop Relat Res.2010;468(5):1316-1324.
[18] 郑召民,蓝天华,吴广良. 带血供骨移植加骨形态发生蛋白治疗股骨头坏死塌陷的初步报告[J].中华创伤杂志,1999,15(5): 355-336.
[19] 徐卫群.补肾健骨汤治疗股骨头缺血性坏死的疗效研究[J].中医临床研究,2011,3(16):88-90.
[20] 何伟,陈镇秋,张庆文.补肾活血中药治疗股骨头坏死临床研究[J].新中医,2012,44(4):50-51.
[21] 张俐,曾勤,李楠.活血化瘀汤影响成骨细胞功能的实验研究[J].中国中医骨伤科杂志,2004,12(1):1-4.
[22] 万蓉,林诗富,林娜,等.不同治法方药对激素性股骨头坏死的骨组织形态学影响[J].中国骨伤,2010,23(12): 40-44.
[23] 孔祥英,万蓉,李莉,等.不同治法方药对激素性股骨头坏死鸡成骨相关因子的影响[J].中国中药杂志,2011,36(5:614-617.
[24] 茆军,郭玉成.补肾通络汤治疗早期非创伤性股骨头坏死的临床研究[J].河北医学,2002,8(7):672-673.
[25] 万蓉,李莉,孔祥英,等.不同治法方药对激素性股骨头坏死鸡股骨头OPG,RANKL,mRNA表达的影响[J].中国实验方剂学杂志, 2011,17(8):149-153.
[26] 李慧英,王义生.中药配合髓芯减压植骨空心螺钉支撑术治疗股骨头坏死的临床研究[J].中华中医药杂志,2011,26(8): 1876-1878.
[27] 孙志涛,周正新,牛维,等.骨蚀宁胶囊对激素性股骨头坏死模型兔凝血机制的影响[J].中国组织工程研究,2012,16(7):1295-1298.
[28] 王大伟,史宝明,李小峰,等.三七总皂苷干预股骨头缺血性坏死兔成骨细胞护骨素基因的表达[J].中国组织工程研究与临床康复, 2011,15(20):3728-3732.
[29] 邱海鹏,陈卫衡.中晚期股骨头坏死中医综合治疗的临床研究[J].北京中医药,2010,29(1):43-45.
[30] 王昌兴,沈建国,姜滔,等.持续局部丹参和肝素灌注治疗股骨头坏死疗效分析[J].中国骨伤,2010,23(5):383-385.
[31] Rosenwasser MP, Garino JP, Kiernan HA, et al.Long term follow up of thorough debridement and cancellous cone grafting of the femoral head for avascular necrosis. Clin Orthop Relat Res. 1994;(306):17-27.
[32] Jones JP Jr. Concepts of etiology and early pathogenesis of osteonecrosis. Instr Course Lect. 1994;43:499-512.
[33] Kenzora JE, Glimcher MJ. Accumulative cellstress: the multifactorial etiology of idiopathicosteonecrosis. Orthop Clin North Am. 1985;16:669-679.
[34] Mont MA, Etienne G, Ragland PS. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;417:84-92.
[35] Rajpura A, Wright AC, Board TN. Medical management of osteonecrosis of the hip: a review. Hip Int. 2011;21:385-392.
[36] Mont MA, Zywiel MG, Marker DR, et al. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010;92: 2165-2170.
[37] Plenk H Jr, Gstettner M, Grossschmidt K, et al. Magnetic resonance imaging and histology of repair in femoral head osteonecrosis. Clin Orthop Relat Res. 2001;(386):42-53.
[38] Glimcher MJ, Kenzora JE. The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; commments on treatment. Clin Orthop Relat Res. 1979;(140):273-312.
[39] Chen CH, Chang JK, Lai KA, et al. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter,prospective, randomized, double-blind,placebo-controlled study. Arthritis Rheum.2012;64:1572-1578.
[40] Sugioka Y, Hotokebuchi T, Tsutsui H. Transtrochanteric anterior rotational osteotomy for idiopathic and steroid-induced necrosis of the femoral head.Indications and long-term results. Clin Orthop Relat Res. 1992;(277):111-120. |